Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Harbinger Health has raised $100.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Harbinger Health's investors include Modi Ventures, Flagship Pioneering, Pictet Private Equity Investors S.A., Partners Investment, M&G Investments.
Harbinger Health is headquartered in Cambridge, United States.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Harbinger Health is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Harbinger Health — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/harbinger-health. Accessed August 14, 2026.
VCBacked. (2025). Harbinger Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/harbinger-health
{{cite web |title=Harbinger Health — Funding & Investors |url=https://www.vcbacked.co/company/harbinger-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated